Understanding the Basis of Fidelity in Eukaryotic Recombinases
Understanding the Basis of Fidelity in Eukaryotic Recombinases
批准号:
9544168
负责人:
Justin B Steinfeld
金额:
$4.05万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-06-30
关键词:
AddressAllelesAmino AcidsAneuploidyBRCA1 MutationBRCA2 MutationBehaviorBindingBiochemicalBiochemical GeneticsBiologicalBiological AssayBiophysicsCellsChimera organismChimeric ProteinsChromosomal RearrangementChromosomesDNADNA BindingDNA Binding DomainDNA DamageDNA RepairDNA SequenceDefectDiseaseDouble Strand Break RepairDown SyndromeElementsEngineeringEnsureEukaryotaFailureFamilyFilamentGenetic RecombinationGenomeGoalsGrowthHomologous GeneHumanIndividualInfertilityInvestigationLeadLifeLinkMaintenanceMalignant NeoplasmsMediatingMeiosisMeiotic RecombinationMitosisMitoticMitotic RecombinationMonitorMutationOrganismPaperPathway interactionsProcessPropertyProteinsPublishingRad51 recombinaseReproductionRoleSaccharomyces cerevisiaeSamplingSequence HomologsSeriesSingle Nucleotide PolymorphismSingle-Stranded DNASister ChromatidSpontaneous abortionTestingTriplet Multiple BirthTrisomyYeastsbiophysical propertiesdesignds-DNAexperimental studygenetic approachgenetic informationgenome integrityhomologous recombinationin vivoinsightrecombinaserepairedresponsesingle molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In order to survive, all organisms have evolved various mechanisms for repairing damaged
DNA. In the case of double-stranded breaks (DSBs), homologous recombination (HR) is a critical
repair mechanism that uses homologous DNA as a template for repair. Failures in mitotic
recombination can lead to chromosomal rearrangements and cancer in humans, as seen in BRCA1
and BRCA2 mutations and failures in meiotic recombination can lead to infertility, miscarriage, and
aneuploidy disorders, such as Downs Syndrome.
Upon formation of a DSB, the damaged DNA is processed through a series of steps eventually
leaving single-stranded DNA overhangs covered in a filament of proteins called recombinases. These
recombinases then search the genome to find a homologous sequence, which can then be used as a
template for repair of the damaged DNA. Eukaryotes have two recombinases, Rad51 and Dmc1.
Rad51 is the only recombinase during mitotic HR, whereas, Dmc1 is expressed exclusively during
meiosis. It is not known why most eukaryotes have two recombinases. However, a recent paper
published in this lab demonstrated the first biochemical/biophysical difference between Rad51 and
Dmc1. When presented with a mismatch during homologous DNA pairing, Dmc1 seems to stabilize
the mismatch, while Rad51 appears to destabilize the mismatch. This differential response may
reflect the unique biological roles of each recombinase: Rad51 is responsible for mitotic HR, and
typically utilizes an identical sister chromatid as a template for repair; In contrast, Dmc1 must utilize
homologs of different parental origins for meiotic HR. We propose that the ability of Dmc1 to stabilize
mismatches reflects a requirement to promote recombination between template bearing single
nucleotide polymorphisms during meiosis.
In this proposal, we want to understand what are the structural elements that allow Rad51 and
Dmc1 to behave differently to mismatches. We will identify DNA-binding regions of the two
recombinases, determine amino acids that are uniquely conserved within each of the recombinases
and swap these elements in order to make chimeric proteins. We will test whether these chimeric
proteins produce the opposite response to mismatches as compared to their wild type forms. In the
proposal, I have already demonstrated that I can create a Rad51 chimera that can stabilize
mismatches and will attempt to create a Dmc1 chimera that can destabilize mismatches. I will then
address the biological significance of mismatch (de)stabilization by incorporating my chimeras into
yeast genomes and monitoring mitotic and meiotic HR in vivo. This proposal will attempt to provide
further insight into and significance of the fidelity of eukaryotic recombination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金